Key result
Primary percutaneous coronary intervention in patients with STEMI triggered rapid systemic DNA damage and immediate PARP-1 activation in circulating leukocytes.
Why the study?
Does primary percutaneous coronary intervention (PCI) induce PARP activation and oxidative DNA damage in circulating leukocytes in patients with ST segment elevation acute myocardial infarction?
Observational (n=30)
Does primary percutaneous coronary intervention (PCI) induce PARP activation and oxidative DNA damage in circulating leukocytes in patients with ST segment elevation acute myocardial infarction?
p-value: p=<0.005
This study provides the first direct clinical evidence that myocardial ischemia and reperfusion during primary PCI trigger immediate PARP activation and oxidative DNA damage in human circulating leukocytes.
PCI-associated PARP-1 activation in STEMI may reflect reperfusion injury; hypothesis-generating for targeted therapies, should not change practice.
Reactive free radical and oxidant production leads to DNA damage during myocardial ischemia/reperfusion. Consequent overactivation of poly(ADP-ribose) polymerase (PARP) promotes cellular energy deficit and necrosis. We hypothesized that PARP is activated in circulating leukocytes in patients with myocardial infarction and reperfusion during primary percutaneous coronary intervention (PCI). In 15 patients with ST segment elevation acute myocardial infarction, before and after primary PCI and 24 and 96 h later, we determined serum hydrogen peroxide concentrations, plasma levels of the oxidative DNA adduct 8-hydroxy-2'-deoxyguanosine (8OHdG), tyrosine nitration, PARP activation, and translocation of apoptosis-inducing factor (AIF) in circulating leukocytes. Plasma 8OHdG levels and leukocyte tyrosine nitration were rapidly increased by PCI. Similarly, poly(ADP-ribose) content of the leukocytes increased in cells isolated just after PCI, indicating immediate PARP activation triggered by reperfusion of the myocardium. In contrast, serum hydrogen peroxide concentrations and the translocation of AIF gradually increased over time and were most pronounced at 96 h. Reperfusion-related oxidative/nitrosative stress triggers DNA damage, which leads to PARP activation in circulating leukocytes. Translocation of AIF and lipid peroxidation occurs at a later stage. These results represent the first direct demonstration of PARP activation in human myocardial infarction. Future work is required to test whether pharmacological inhibition of PARP may offer myocardial protection during primary PCI.
No takes yet. Share an insight, caveat, or question.
Tóth-Zsámboki et al. (2007) conducted an observational in Acute ST-segment elevation myocardial infarction (n=30). Primary percutaneous coronary intervention (PCI) vs. Stable angina patients undergoing elective PCI or coronary angiography was evaluated on PARP-1 activation and oxidative DNA damage (8OHdG levels) in circulating leukocytes (p=<0.005). Primary percutaneous coronary intervention in patients with STEMI triggered rapid systemic DNA damage and immediate PARP-1 activation in circulating leukocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: